Jonathan Alspaugh Aeglea Bio Therapeutics, Inc. (AGLE) insider trading activity

AGLE Quotes by TradingView

Jonathan Alspaugh is President and CFO of Aeglea BioTherapeutics, Inc.. Currently has a direct ownership of 165,372 shares of AGLE, which is worth approximately $4.57 Million. The most recent transaction as insider was on Mar 11, 2022, when has been sold 75,000 shares (Common Stock) at a price of $2.08 per share, resulting in proceeds of $156,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 165K
0% 3M change
0% 12M change
Total Value Held $4.57 Million

Jonathan Alspaugh Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 11 2022
BUY
Open market or private purchase
$156,000 $2.08 p/Share
75,000 Added 31.2%
165,372 Common Stock
Dec 09 2021
BUY
Open market or private purchase
$186,000 $3.72 p/Share
50,000 Added 35.62%
90,372 Common Stock
Aug 18 2021
BUY
Open market or private purchase
$48,384 $6.72 p/Share
7,200 Added 15.13%
40,372 Common Stock
Aug 17 2021
BUY
Open market or private purchase
$152,048 $6.5 p/Share
23,392 Added 41.35%
33,172 Common Stock
Aug 16 2021
BUY
Open market or private purchase
$62,299 $6.37 p/Share
9,780 Added 50.0%
9,780 Common Stock
JA

Jonathan Alspaugh

President and CFO
Austin, TX

Track Institutional and Insider Activities on AGLE

Follow Aeglea BioTherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGLE shares.

Notify only if

Insider Trading

Get notified when an Aeglea Bio Therapeutics, Inc. insider buys or sells AGLE shares.

Notify only if

News

Receive news related to Aeglea BioTherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AGLE